Pinkevych, M., Kent, S. J.
, Tolstrup, M., Lewin, S. R., Cooper, D. A.
, Søgaard, O. S., Rasmussen, T. A., Kelleher, A. D., Cromer, D. & Davenport, M. P. (2016).
Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days.
PLoS Pathogens,
12(8), e1005740. Article e1005740.
https://doi.org/10.1371/journal.ppat.1005740Thomsen, M. B., Lillethorup, T. P., Jakobsen, S., Nielsen, E. H., Simonsen, M.
, Wegener, G., Landau, A. M. & Tasker, A. (2016).
Neonatal domoic acid alters in vivo binding of [(11)C]yohimbine to α2-adrenoceptors in adult rat brain.
Psychopharmacology,
233(21), 3779-3785.
https://doi.org/10.1007/s00213-016-4416-5
Damsgaard, J.
, Andersen, H., Hjerrild, S., Marinovskij, E., Deutch, S., Schembri, A.
, Tarp, B. D., Kristensen, L. H., Age Lindberg, J.
, Erlandsen, M. & Leutscher, P. D. C. (2016).
Neuropsychiatric symptoms among adult patients with aseptic meningitis: a prospective case series.
Acta Psychiatrica Scandinavica,
133(5), 426-427.
https://doi.org/10.1111/acps.12539Borggren, M., Jensen, S. S., Heyndrickx, L., Palm, A. A., Gerstoft, J., Kronborg, G.
, Hønge, B. L., Jespersen, S., da Silva, Z. J., Karlsson, I. & Fomsgaard, A. (2016).
Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and Denmark.
AIDS Research and Human Retroviruses,
32(5), 434-442.
https://doi.org/10.1089/AID.2015.0118Dyrehave, C., Rasmussen, D. N.
, Hønge, B. L., Jespersen, S., Correia, F. G., Medina, C.
, Wejse, C., Rodkjaer, L. & Bissau HIV Cohort Study Group (2016).
Nonadherence is Associated with Lack of HIV-Related Knowledge: A Cross-Sectional Study among HIV-Infected Individuals in Guinea-Bissau.
Journal of the International Association of Providers of AIDS Care,
15(4), 350–358.
https://doi.org/10.1177/2325957415599211
Öbrink-Hansen, K., Jensen-Fangel, S., Brock, B., Hardlei, T. F., Adelfred, A., Nejatbakhsh, Y.
, Kragh Thomsen, M. & Petersen, E. (2016).
Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations.
Journal of Cystic Fibrosis,
15(2), e13-e14.
https://doi.org/10.1016/j.jcf.2015.10.005
Hinton, T. M.
, Zuwala, K., Deffrasnes, C., Todd, S., Shi, S., Marsh, G. A., Dearnley, M.
, Wohl, B. M., Tolstrup, M. & Zelikin, A. N. (2016).
Polyanionic Macromolecular Prodrugs of Ribavirin: Antiviral Agents with a Broad Spectrum of Activity.
Advanced Healthcare Materials,
5(5), 534-540.
https://doi.org/10.1002/adhm.201500841